Electromed, Inc. (ELMD) stock
Close on Nov 12, 2026Market cap $208.90MP/E 18.1Yield –
Electromed, Inc. grew revenue 14.1% to $75.57M over the twelve months to Sep 30, 2026. Operating income rose 41.5% to $14.70M, moving the operating margin from 15.7% to 19.5%. Free cash flow was $8.70M, down 0.8% from a year earlier. At the latest close the market valued the company at $208.90M, 18.1 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $208.90M
- P/E ratio
- 18.1
- Price to sales
- 2.76
- Price to book
- 3.98
- Dividend yield
- –
- Free cash flow yield
- 4.17%
Fundamentals
- Revenue
- $75.57M
- Net income
- $11.93M
- EPS, diluted
- $1.38
- Free cash flow
- $8.70M
- Book value per share
- $5.99
- Diluted shares
- 9M
Trading
- Next earnings
- Feb 9, 2027 (estimated, during market hours)
- Previous close
- $24.96
- Open
- $25.00
- Day's range
- $23.64 – $25.26
- Volume
- 123,414
- Average volume (20 days)
- 49,548
- Index membership
- Russell 2000 (since Jun 2025)
- Beta (5 years)
- 0.50
- 52-week range
- $23.01 – $47.40
- RSI (14 days)
- 33.2
- Volatility (1 year)
- 50.6%
- Relative volume
- 1.16×
- WACC
- 7.4%
On 1 of our idea list: Fallen quality
Index membership is inferred from the holdings of funds that track each index (IWM), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | ELMD | S&P 500 | Difference | ELMD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -11.2% | -2.7% | −8.5 pts | ||
| 3 months | -41.2% | -1.7% | −39.5 pts | ||
| Year to date | -14.3% | +11.9% | −26.1 pts | ||
| 1 year | -1.6% | +12.0% | −13.6 pts | ||
| 3 years | +143.6% | +78.2% | +65.4 pts | +34.6% | +21.2% |
| 5 years | +103.8% | +73.2% | +30.6 pts | +15.3% | +11.6% |
| 10 years | +538.6% | +309.6% | +229.0 pts | +20.4% | +15.1% |
Fifteen years at a glance
Fiscal years 2012 to 2026 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Electromed filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About Electromed
Electromedical & Electrotherapeutic Apparatus
Electromed, Inc. develops, manufactures, markets, and sells medical devices that provide airway clearance therapy. Its core product offering is the SmartVest Airway Clearance System, available in models such as SmartVest SQL and SmartVest Clearway, along with Single Patient Use garments and wraps. These devices use high-frequency chest wall oscillation to clear retained mucus from the lungs. Electromed primarily serves individuals suffering from compromised pulmonary function associated with conditions like bronchiectasis, cystic fibrosis, and neuromuscular diseases. Its customer base includes homecare patients as well as inpatient populations within hospital intensive care and post-surgical units.
Company profile, executives and historyElectromed stock: common questions
What is Electromed's stock price?
ELMD closed at $24.97 on Nov 12, 2026, up 0.04% on the day. Over the past 52 weeks it traded between $23.01 and $47.40.
What is Electromed's market cap?
Electromed was worth $208.90M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is ELMD's P/E ratio?
ELMD trades at 18.1 times earnings, based on diluted earnings per share of $1.38 over the twelve months to Sep 30, 2026.
How much revenue does Electromed make?
Electromed reported revenue of $75.57M for the twelve months to Sep 30, 2026, up 14.1% from a year earlier.
Does Electromed pay a dividend?
No. Electromed has not paid a cash dividend over the last twelve months.
When does Electromed report earnings next?
Electromed is expected to report Q2 FY2027 results on Feb 9, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has ELMD stock performed over the past year?
Including dividends, ELMD returned -1.6% over the past year, against +12.0% for the S&P 500.
How many ELMD shares are sold short?
0M shares were sold short at the latest FINRA report, 2.44% of the float, or 4.8 days of average trading volume.
Who are Electromed's competitors?
Companies most similar to Electromed by business, industry and size include ECOR, FOCL, LUNG, VASO, IRIX.
See a number that looks wrong?